Pretium Resources (PVG) Skyrockets on Bulk Sample Results, Biogen (BIIB) on CHMP Determination

Shares of Pretium Resources Inc. (PVG) jumped $2.34 (or +79.86%) to $5.27 on Friday's market activity, after the company reported that 4,215 ounces of gold have been produced from 8,090 dry tonnes of excavated material from the Valley of the Kings Bulk Sample Program. Approximately 1,815 wet tonnes remain to be processed.

The results to date surpass the target of 4,000 ounces of gold projected to be produced from the entire 10,000 tonnes of material excavated for the Program. Processing is continuing on track and is expected to be completed by the first week of December (after a week-long mill shutdown for the U.S. Thanksgiving holiday).

Shipment and sale of the gravity concentrate has commenced, with shipment of the flotation concentrate to commence on completion of processing. The final amount of gold production will be announced at the end of processing and assaying which is expected by mid-December.

PVG was also upgraded from Market Perform to Outperform by brokerage firm BMO Capital Markets

PVG is creating value through gold at its high-grade gold Brucejack Project, located in northern British Columbia. Processing of the 10,000-tonne Valley of the Kings bulk sample is expected to be completed this quarter. Permitting of a high-grade underground gold mine at Brucejack is underway, with commercial production targeted to commence in 2016.

More about Pretium Resources Inc. (PVG) at www.pretivm.com

**

Industry analyst firm Forrester estimates the B2B e-commerce market is expected to reach $559 billion by the end of 2013.

According to comScore, 188.7 million people in the US watched 46 billion online content videos in September 2013. The average American spent more than 20 hours watching online video.

Looking to deliver value for its stockholders in both the near and long term, Crown Equity Holdings Inc. (CRWE) is refocusing its strategic plan to improve the potential future growth for the company, targeting the multi-billion dollar online video-sharing and online b2b markets, with its Division CRWETube (www.crwetube.com) and its iB2B Global project, respectively.

As a worldwide online multi-media publisher, CRWE‘s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com.

**

The price of Biogen Idec Inc. (BIIB) stock soared after the company reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has determined that dimethyl fumarate in TECFIDERA qualifies as a new active substance. This designation will provide 10 years of regulatory exclusivity for TECFIDERA in the European Union (EU).

The new active substance determination follows a positive opinion by the CHMP in March 2013 recommending marketing authorization in the EU for TECFIDERA as a first-line oral treatment for adults with relapsing-remitting multiple sclerosis

The CHMP’s determination will now be referred to the European Commission, which grants marketing authorization for medicines in the EU.

TECFIDERA, an oral therapy for relapsing forms of multiple sclerosis, is currently approved in the United States, Canada and Australia, and is under review by regulatory authorities in the European Union.

If approved, TECFIDERA will mark the fourth therapy that BIIB offers to people living with multiple sclerosis in the European Union.

Through cutting-edge science and medicine, BIIB discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders.

More about Biogen Idec Inc. (BIIB) at www.biogenidec.com.

**

Cimarex Energy Co. (XEC) stock was upgraded from Hold to Buy and price target of $120 by brokerage firm Stifel. XEC shares climbed $1.86 (or +1.87%), closing at $101.24 on Friday.

XEC recently reported its financial results. For the third quarter 2013, XEC posted net income of $138.4 million, or $1.59 per diluted share, compared to $84.3 million, or $0.97 per diluted share in the same period the prior year.

According to its business outlook, XEC estimates fourth quarter 2013 total company volumes to average 714-734 MMcfe per day. As a result, 2013 total company volumes are now projected to average 695-700 MMcfe/d, 11 to 12%v growth over 2012 with oil volumes projected to grow 18%. Adjusted for property sales in 2012, production is expected to grow 14%.

XEC is an independent oil and gas exploration and production company with principal operations in the Mid-Continent and Permian Basin areas of the U.S.

More about Cimarex Energy Co. (XEC) at www.cimarex.com.

**

Read Full Disclaimer at www.drstockpick.com/disclaimer